SlideShare a Scribd company logo
2 Mar 2012




                                     GESTATIONAL DIABETES
                                         MANAGEMENT
                                 Iris Thiele Isip Tan MD, MSc, FPCP, FPSEM
                             Clinical Associate Professor, UP College of Medicine


Wednesday, November 21, 12
Q1

                             Which of the following
                             women will you screen for
                             gestational diabetes?


                             a) 25 y.o. G1P0 whose mother has
                             diabetes

                             b) 38 y.o. G3P0 with recurrent first-
                             trimester abortions

                             c) 27 y.o. G2P1

                             d) All of the above



Wednesday, November 21, 12
Unite for Diabetes CPG 2010




                                All pregnant women
                             should be screened for GDM.


Wednesday, November 21, 12
Risky



                             Filipino women are at increased
                             risk for diabetes in pregnancy.

                             ASGODIP Data                             n/N
                             Low risk                             35/853
                             High risk                           136/350
                                                                171/1203
                             Overall
                                                                  14.2%
                                         Litonjua AD et al. AFES Study Group on Diabetes in Pregnancy:
                                                   Preliminary Data on Prevalence. PJIM 1996:34:67-68.




Wednesday, November 21, 12
Risky
                                   Macrosomia                                  Shoulder Dystocia




                                                                Increased
                                                                  risk of
                                                                 perinatal
                                                                morbidity




                                    Birth injuries                                Hypoglycemia
                  http://www.flickr.com/photos/mikewade/3267336862/      http://www.flickr.com/photos/jessicafm/280232106/
                     http://www.flickr.com/photos/clairity/1385780317/   http://www.flickr.com/photos/tessawatson/379265818/



Wednesday, November 21, 12
Risky
                              Cesearean Section                                     Preeclampsia




                                                               Increased
                                                                 risk of
                                                                maternal
                                                               morbidity




                     Pregnancy-induced hypertension                         Type 2 diabetes mellitus
                                                                            http://www.flickr.com/photos/ulybug/512369383/
                       http://www.flickr.com/photos/j2dread/4501366303/
                                                                         http://www.flickr.com/photos/78428166@N00/4921825364/



Wednesday, November 21, 12
International Diabetes
                             Federation (2009)
                             Global Guideline on
                             Pregnancy and Diabetes




                             “... women with GDM without risk
                             factors appear to be no different from
                             women with GDM and risk factors.”


Wednesday, November 21, 12
Q1

                             Which of the following
                             women will you screen for
                             gestational diabetes?


                             a) 25 y.o. G1P0 whose mother has
                             diabetes

                             b) 38 y.o. G3P0 with recurrent first-
                             trimester abortions

                             c) 27 y.o. G2P1

                             d) All of the above



Wednesday, November 21, 12
Q2


                             Which of the following factors
                             best predict risk of GDM?



                             a) prior history of GDM

                             b) glucosuria

                             c) family history of diabetes

                             d) prior macrosomic baby




Wednesday, November 21, 12
Prior history of GDM (OR 23.6 [95%CI 11.6, 48.0])3
                       Glucosuria (OR 9.04 [95%CI 2.6, 63.7]2; PPV 50% 4)
                       Family history of diabetes (OR 7.1 [95%CI 5.6, 8.9]1;
                       OR 2.74 [95%CI 1.47, 5.11]3)
                       Prior macrosomic baby (OR 5.59 [95%CI 2.68, 11.7])3
                       Age >25 years old (OR 1.9 [95%CI 1.3, 2.7]1; OR 3.37
                       [95%CI 1.45, 7.85]3)




                               Risk Factors for GDM
                                                             UNITE
                                                              CPG



Wednesday, November 21, 12
Diagnosis of polycystic ovary syndrome (OR 2.89
                       [95%CI 1.68, 4.98])5

                       Overweight or obese before pregnancy
                       (BMI >27 kg/m2 OR 2.3 [95%CI 1.6, 3.3]1; BMI>30 kg/
                       m2 OR 2.65 [95%CI 1.36, 5.14]3
                       Macrosomia in current pregnancy (PPV 40% 4)
                       Polyhydramnios in current pregancy (PPV 40% 4)
                       Intake of drugs affecting carbohydrate metabolism




                              Risk Factors for GDM
                                                            UNITE
                                                             CPG



Wednesday, November 21, 12
Q2


                             Which of the following factors
                             best predict risk of GDM?



                             a) prior history of GDM

                             b) glucosuria

                             c) family history of diabetes

                             d) prior macrosomic baby




Wednesday, November 21, 12
Q3


                                For pregnant women, when
                                should testing be done?


                             a) Test high-risk women at the soonest
                             possible time
                             b) Women without risk factors should be
                             tested between 24-28 wks AOG
                             c) Testing for gestational diabetes should still
                             be carried out in women at risk even beyond
                             24-28 wks AOG
                             d) All of the above



Wednesday, November 21, 12
ASGODIP (Veterans Memorial Medical Center)
                                                      AOG tested
                                %                       21-30    31-40
                                            <20 weeks
                                                        weeks    weeks
                                              n=19
                                                        n = 74   n = 60
                             Negative
                                                    95                   92                    85
                             for GDM
                              Positive
                                                     5                    8                    15
                             for GDM
                                   Bihasa MTG et al. Screening for gestational diabetes: Report from ASGODIP
                                 participating hospital: Veterans Memorial Medical Center. PJIM 1996:34:57-61.


                                                                                                 Testing




Wednesday, November 21, 12
Q3


                                For pregnant women, when
                                should testing be done?


                             a) Test high-risk women at the soonest
                             possible time
                             b) Women without risk factors should be
                             tested between 24-28 wks AOG
                             c) Testing for gestational diabetes should still
                             be carried out in women at risk even beyond
                             24-28 wks AOG

                             d) All of the above



Wednesday, November 21, 12
Q4


                             Which test should be used to
                             screen for GDM?



                                     a) 75-g OGTT

                                     b) 100-g OGTT

                                     c) 50-g GCT

                                     d) FBS



Wednesday, November 21, 12
★   Capillary blood glucose
                             ★   RBS
                             ★   Fructosamine
                             ★   FBS
                             ★   Hba1c
                             ★   Urine glucose




                                    NOT to be used
                                 for diagnosis of GDM
                                                           Use
                                                           OGTT



Wednesday, November 21, 12
One-
                                                                                 step




                             50-g glucose           Oral glucose
                               challenge       tolerance test (OGTT)
                              test (GCT)           75-g or 100 g



                                             “A one-stage definitive
                                            procedure is preferred.”
                                               International Diabetes Federation (2009)
                                               Global Guideline on Pregnancy & Diabetes




Wednesday, November 21, 12
OGTT




                                                     100-g OGTT
                                                     high glucose
                                                      load often
                                                     unpalatable
                                        100-g OGTT
                                          duration
                                                    75-g OGTT
                             100-g more   3 hours
                                                   international
                             cumbersome;
                                                     standard in
                               4 blood
                                                    non-pregnant
                               samples




Wednesday, November 21, 12
CPG




                         Philippine Diabetes CPG has
                         endorsed the use of the 75-g OGTT.



Wednesday, November 21, 12
Q4


                             Which test should be used to
                             screen for GDM?



                                     a) 75-g OGTT

                                     b) 100-g OGTT

                                     c) 50-g GCT

                                     d) FBS



Wednesday, November 21, 12
Q5


                             Which of the following is true
                             of the OGTT procedure?


                             a) Low CHO intake for past 3 days

                             b) Fast for 10 to 16 h

                             c) Slow walking is not permitted

                             d) Supine position during test




Wednesday, November 21, 12
CHO intake of at least 150 g/day 3 days prior
                             Fast for 10 to 16 hours
                             75 grams of anhydrous dextrose powder as
                             chilled 25% solution (400 cc) flavored with
                             calamansi
                               Drink within 5 minutes (first swallow is time zero)
                               Terminate test should nausea and vomiting occur

                             Collect samples at 0, 1 and 2 hours

                                                                            OGTT




Wednesday, November 21, 12
Abstain from tobacco, coffee, tea,
                             food and alcohol during test

                             Sit upright and quietly during the test

                             Slow walking is permitted but avoid
                             vigorous exercise



                                                                  OGTT




Wednesday, November 21, 12
Q5


                             Which of the following is true
                             of the OGTT procedure?


                             a) Low CHO intake for past 3 days

                             b) Fast for 10 to 16 h

                             c) Slow walking is not permitted

                             d) Supine position during test




Wednesday, November 21, 12
Q6


                               Which of the following results
                               is/are consistent with GDM?


                             a) 75-g OGTT: FBS 90 1h 190 2h 150

                             b) 75-g OGTT: FBS 98 1h 190 2h 150

                             c) 100-g OGTT: FBS 98 1h 190 2h 150
                             3h 140

                             d) All of the above



Wednesday, November 21, 12
CPG




                             Thresholds          ADA            IADPSG
                                 for
                              diagnosis     100-g      75-g      75-g*

                             FBS              95        95          92
                             1h              180       180         180
                             2h              155       155         153
                             3h              140         -           -

                                   * Requires only 1 threshold value exceeded




Wednesday, November 21, 12
Q6


                               Which of the following results
                               is/are consistent with GDM?


                                                             IADPSG
                             a) 75-g OGTT: FBS 90 1h 190 2h 150
                                                                  ADA
                             b) 75-g OGTT: FBS 98 1h 190 2h 150

                             c) 100-g OGTT: FBS 98 1h 190 2h 150
                             3h 140                              ADA
                             d) All of the above



Wednesday, November 21, 12
CPG




                             Thresholds          ADA            IADPSG
                                 for
                              diagnosis     100-g      75-g      75-g*

                             FBS              95        95          92
                             1h              180       180         180
                             2h              155       155         153
                             3h              140         -           -

                                   * Requires only 1 threshold value exceeded




Wednesday, November 21, 12
OGTT



                             ACOG recommends against
                             IADPSG consensus
                       Diagnosis of GDM based on the 1-step
                       screening and diagnosis test outlined in the
                       IADPSG guidelines is not recommended at
                       this time because there is no evidence that diagnosis
                       using these criteria leads to clinically significant
                       improvement in maternal or newborn outcomes, and it
                       would lead to a significant increase in healthcare costs.

                                          ACOG Committee on Obstetric Practice. Screening & Diagnosis of
                                  Gestational Diabetes Mellitus. Obstetrics & Gynecology 2011; 118(3):751-3




Wednesday, November 21, 12
Q7


                                Which of the following is TRUE of
                                dietary management for GDM?



                             a) Do NOT prescribe less than 1500 cal/day for
                             multiple pregnancy
                             b) For overweight women, reduce energy
                             intake by no more than 30% of habitual intake
                             c) Monitor urine ketones at bedtime to detect
                             starvation ketonuria
                             d) Non-caloric sweeteners are NOT allowed.




Wednesday, November 21, 12
Diet



                               Recommended Daily
                                  Caloric Intake


                             Pregravid BMI Category                                  kcal/kg/day
                         Low (BMI <18.5 kg/m2)                                          36-40
                         Normal (BMI 18.5-24.9 kg/m2)                                     30
                         High (BMI 25-29.9 kg/m2)                                         24
                         Obese (BMI >29.9 kg/m2)                                          12




                                     Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009)




Wednesday, November 21, 12
Diet




                             For considerably overweight women
                             with GDM, reduce energy intake by no
                             more than 30% of habitual intake


                             Total cal/day = 1,800-2,000
                             Not less than 2,000 cal/day if multiple
                             pregnancy

                                                        International Diabetes Federation (2009)
                                                    Global Guideline on Pregnancy and Diabetes




Wednesday, November 21, 12
“Non-c aloric sweeteners may
                        be used in moderation.”
                                         ADA GDM Position Statement 2004




Wednesday, November 21, 12
Q7


                                Which of the following is TRUE of
                                dietary management for GDM?



                             a) Do NOT prescribe less than 1500 cal/day for
                             multiple pregnancy
                             b) For overweight women, reduce energy
                             intake by no more than 30% of habitual intake
                             c) Monitor urine ketones at bedtime to detect
                             starvation ketonuria
                             d) Non-caloric sweeteners are NOT allowed.




Wednesday, November 21, 12
Q8

                             For a woman with normal BMI,
                             what is the allowed weight gain
                             in pregnancy?




                                  a) <28-40 lbs
                                  b) 25-35 lbs
                                  c) 15-25 lbs
                                  d) 11-20 lbs




Wednesday, November 21, 12
Weight gain during pregnancy
         12.5 kg             British cohort of >3800 primigravidae
                             eating without restriction

                              Product of conception
                                 Fetus, placenta, amniotic fluid

                              Maternal tissue expansion
                                 Uterus, breasts, blood volume

                              Maternal fat reserve
                                                                     Text




Wednesday, November 21, 12
Rates of weight gain*
                         Prepregnancy Total weight
                                                       2nd and 3rd
                              BMI      gain (lbs)
                                                   trimester (lbs/week)
                         Underweight                         1
                                        <28-40
                         BMI <18.5                        (1-1.3)
                         Normal weight                                1
                                                  25-35
                         BMI 18.5-24.9                             (0.8-1)
                         Overweight                                   0.6
                                                  15-25
                         BMI 25.0-29.9                             (0.5-0.7)
                         Obese                                        0.5
                                                  11-20
                         BMI >30.0                                 (0.4-0.6)
                             * Assume a 0.5-2.0 kg (1.1-4.4 lbs)
                               weight gain in the first trimester

                                                                               IOM




Wednesday, November 21, 12
Q8

                             For a woman with normal BMI,
                             what is the allowed weight gain
                             in pregnancy?




                                  a) <28-40 lbs
                                  b) 25-35 lbs
                                  c) 15-25 lbs
                                  d) 11-20 lbs




Wednesday, November 21, 12
Q9


                                 Which of the following is TRUE of
                                 self-monitoring of blood glucose?



                             a) For women on dietary intervention alone,
                             monitor BG 6x a day.
                             b) For women treated with insulin, postprandial
                             monitoring is superior to pre-prandial.
                             c) If on insulin, test BG before breakfast to detect
                             hypoglycemia.
                             d) Daily SMBG does not appear to be superior to
                             intermittent office monitoring.



Wednesday, November 21, 12
“For women treated with insulin, limited
                             evidence indicates that postprandial
                             monitoring is superior to preprandial
                             monitoring.”           ADA GDM Position Statement 2004


Wednesday, November 21, 12
Diet only
                             Monitor BG 4x a day (prebreakfast and 1 h
                             after the first bite of food at each meal)
                                                                   AACE 2007



Wednesday, November 21, 12
Q9


                                 Which of the following is TRUE of
                                 self-monitoring of blood glucose?



                             a) For women on dietary intervention alone,
                             monitor BG 6x a day. 3x a day
                             b) For women treated with insulin, postprandial
                             monitoring is superior to pre-prandial.
                             c) If on insulin, test BG before breakfast to detect
                             hypoglycemia. Test at night
                             d) Daily SMBG does not appear to be superior to
                             intermittent office monitoring.



Wednesday, November 21, 12
Q10


                                 What are the targets for
                                 SMBG?


                             a) Between 60 to 90 mg/dL for fasting and less
                             than 120 mg/dL 1 hour after the first bite of food
                             at each meal (postprandial)
                             b) Not more than 95 mg/dL for fasting and less
                             than 120 mg/dL 2 hours postprandial
                             c) 90 mg/dL for fasting and less than 140 mg/dL
                             2 hours postprandial
                             d) None of the above



Wednesday, November 21, 12
Between 60 to 90 mg/dL (fasting) and
                             less than 120 mg/dL (1 hour after the
                             first bite of food at each meal)
                                                              AACE 2007



Wednesday, November 21, 12
Q10


                                 What are the targets for
                                 SMBG?


                             a) Between 60 to 90 mg/dL for fasting and less
                             than 120 mg/dL 1 hour after the first bite of food
                             at each meal (postprandial)
                             b) Not more than 95 mg/dL for fasting and less
                             than 120 mg/dL 2 hours postprandial
                             c) 90 mg/dL for fasting and less than 140 mg/dL
                             2 hours postprandial
                             d) None of the above



Wednesday, November 21, 12
Q11


                             Can we give Metformin
                             for GDM?




                                a) Yes
                                b) No




Wednesday, November 21, 12
★ Use of Metformin or glibenclamide
                             during pregnancy NOT an approved
                             indication

                             ★   Discuss with patients

                             ★   Obtain and document informed consent.

                                                         Canadian Diabetes Association 2008




                                    METFORMIN: Off-label use

                                                                 OHA




Wednesday, November 21, 12
Insulin remains the
                             agent of choice
                             “In poorly resourced areas
                             of the world, the
                             theoretical disadvantages
                             of using oral glucose-
                             lowering agents ... far less
                             than the risks of non-
                             treatment.”                     IDF 2009


                                                            Insulin




Wednesday, November 21, 12
Q11


                             Can we give Metformin
                             for GDM?




                                a) Yes
                                b) No




Wednesday, November 21, 12
Q12


                                  When and how should insulin
                                  be started in GDM?


                             a) Consider insulin when diet and exercise fail to
                             maintain glucose targets in 1-2 weeks
                             b) Ultrasound shows incipient fetal macrosomia
                             (AC >70th percentile)
                             c) Start daily insulin at 0.1-0.3 u/kg BW
                             d) All of the above




Wednesday, November 21, 12
Insulin Initiation
                             ADA Protocol
                             Fasting whole BG >95 mg/dL
                             1-h postprandial whole BG >140 mg/dL
                             2-h postprandial whole BG >120 mg/dL

                             Dr. Jovanovic
                             Fasting plasma glucose >90 mg/dL (5 mmol/L)
                             1-h PP whole BG >120 mg/dL (6.7 mmol/L)
                                                                                                Insulin

                             Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009)


Wednesday, November 21, 12
Q12


                                 When and how should insulin
                                 be started in GDM?


                             a) Consider insulin when diet and exercise fail to
                             maintain glucose targets in 1-2 weeks
                             b) Ultrasound shows incipient fetal macrosomia
                             (AC >70th percentile)
                             c) Start daily insulin at 0.1-0.3 u/kg BW
                             d) All of the above




Wednesday, November 21, 12
Q13


                                Which of the following is true of
                                management during labor?




                             a) Give dextrose-containing IV fluids
                             b) Give short-acting insulin for CBG>140 mg/dL
                             c) Check CBG q hourly.
                             d) All of the above




Wednesday, November 21, 12
Protocol for Spontaneous Delivery

                               Infusion of 500 ml 5% dextrose/saline
                               x4h
                               CBG q 4h
                               Give short-acting insulin for CBG >140
                               mg/dL
                                                                                 L
                             - Do se equal to mmol of CBG i.e. 12 u for 12 mmol/
                                                                            u for
                             - Dose equal to 1/20th of mg/dL of CBG i.e. 12
                             240 mg/dL
                                Omit insulin for CBG <140 mg/dL

                                                                                ASGODIP




Wednesday, November 21, 12
After delivery

                             Resume diet
                             GDMs with high insulin requirements
                             during pregnancy should have
                             glucose profiles
                             Give insulin if BG persistently high
                             (>200 mg/dL)

                                                               ASGODIP




Wednesday, November 21, 12
Q13


                                Which of the following is true of
                                management during labor?




                             a) Give dextrose-containing IV fluids
                             b) Give short-acting insulin for CBG>140 mg/dL
                             c) Check CBG q hourly.
                             d) All of the above




Wednesday, November 21, 12
Q14


                                Which of the following is true of
                                postpartum follow-up?




                             a) Schedule 75-g OGTT 6 weeks after follow-up
                             b) Measure FBS every 3 years
                             c) Advise patient not to get pregnant again
                             d) Breastfeeding should be limited




Wednesday, November 21, 12
Jovanovic L (Ed). Medical Management of
                             Pregnancy Complicated by Diabetes (2009)




                                     Annual follow-up
                                     Measure FBS
                                     Assess weight reduction
                                     Review pregnancy plans

Wednesday, November 21, 12
Ff-up



                                 All patients with prior GDM
                                      should be educated re:
                                       lifestyle modifications

                               Maintain normal body weight:
                                  MNT and physical activity

                                     Women with IFG or IGT
                             postpartum: intensive MNT and
                             individualized exercise program
                                            ADA GDM Position Statement 2004




Wednesday, November 21, 12
Ff-up


                        Planning subsequent
                        pregnancies

                        Plan future pregnancies in
                        consultation with health
                        care provider

                        Assess glucose tolerance
                        prior to conception to
                        assure normoglycemia at
                        time of conception
                                                     Canadian Diabetes Association 2008




Wednesday, November 21, 12
Q14


                                Which of the following is true of
                                postpartum follow-up?




                             a) Schedule 75-g OGTT 6 weeks after follow-up
                             b) Measure FBS every 3 years
                             c) Advise patient not to get pregnant again
                             d) Breastfeeding should be limited




Wednesday, November 21, 12
Thank You
                             http://www.endocrine-witch.net
                                         @endocrine_witch




                                                   Image from http://wthr.frumph.net/




Wednesday, November 21, 12

More Related Content

What's hot

MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANIMANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
lamiaa Gamal
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
Niranjan Chavan
 
Antenatal Steroid for Preterm Birth
Antenatal Steroid for Preterm BirthAntenatal Steroid for Preterm Birth
Antenatal Steroid for Preterm Birth
Muhammad Ilham Aldika Akbar
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
Sabah Salim
 
Fetal Programming of Adult Disease
Fetal Programming of Adult DiseaseFetal Programming of Adult Disease
Fetal Programming of Adult Disease
Stefan Johansson
 
Insulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancyInsulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancy
Nemencio Jr
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancy
sweetututu
 
Thyroid diseases in pregnancy PPT
Thyroid diseases in pregnancy PPTThyroid diseases in pregnancy PPT
Thyroid diseases in pregnancy PPT
sonal patel
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
Iris Thiele Isip-Tan
 
Hyperemesis gravidum
Hyperemesis gravidumHyperemesis gravidum
Hyperemesis gravidum
Mithun Patel
 
Thyroid Disorders in Pregnancy- Dr Shahjada Selim
Thyroid Disorders in Pregnancy- Dr Shahjada SelimThyroid Disorders in Pregnancy- Dr Shahjada Selim
Thyroid Disorders in Pregnancy- Dr Shahjada Selim
Bangabandhu Sheikh Mujib Medical University
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
ikramdr01
 
Diabetes Mellitus in Pregnancy
Diabetes Mellitus in PregnancyDiabetes Mellitus in Pregnancy
Diabetes Mellitus in Pregnancymeducationdotnet
 
Diabetes & Pregnancy
Diabetes & PregnancyDiabetes & Pregnancy
Diabetes & Pregnancy
Dhammike Silva
 
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANIMANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Thyroid diseases in pregnancy
Thyroid diseases in pregnancyThyroid diseases in pregnancy
Thyroid diseases in pregnancy
ikramdr01
 
Thyroid disorders in pregnancy
Thyroid disorders in pregnancyThyroid disorders in pregnancy
Thyroid disorders in pregnancy
Shivshankar Badole
 
Hypoglycemia Hyperglycemia In The Pregnant Patient
Hypoglycemia Hyperglycemia In The Pregnant PatientHypoglycemia Hyperglycemia In The Pregnant Patient
Hypoglycemia Hyperglycemia In The Pregnant PatientKelly Miller
 

What's hot (20)

MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANIMANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
 
Hyperemesis gravidarum
Hyperemesis gravidarumHyperemesis gravidarum
Hyperemesis gravidarum
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
Antenatal Steroid for Preterm Birth
Antenatal Steroid for Preterm BirthAntenatal Steroid for Preterm Birth
Antenatal Steroid for Preterm Birth
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 
Fetal Programming of Adult Disease
Fetal Programming of Adult DiseaseFetal Programming of Adult Disease
Fetal Programming of Adult Disease
 
Insulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancyInsulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancy
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancy
 
Thyroid diseases in pregnancy PPT
Thyroid diseases in pregnancy PPTThyroid diseases in pregnancy PPT
Thyroid diseases in pregnancy PPT
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
 
Hyperemesis gravidum
Hyperemesis gravidumHyperemesis gravidum
Hyperemesis gravidum
 
Thyroid Disorders in Pregnancy- Dr Shahjada Selim
Thyroid Disorders in Pregnancy- Dr Shahjada SelimThyroid Disorders in Pregnancy- Dr Shahjada Selim
Thyroid Disorders in Pregnancy- Dr Shahjada Selim
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
Diabetes Mellitus in Pregnancy
Diabetes Mellitus in PregnancyDiabetes Mellitus in Pregnancy
Diabetes Mellitus in Pregnancy
 
Diabetes & Pregnancy
Diabetes & PregnancyDiabetes & Pregnancy
Diabetes & Pregnancy
 
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANIMANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
 
Thyroid diseases in pregnancy
Thyroid diseases in pregnancyThyroid diseases in pregnancy
Thyroid diseases in pregnancy
 
Thyroid disorders in pregnancy
Thyroid disorders in pregnancyThyroid disorders in pregnancy
Thyroid disorders in pregnancy
 
Hypoglycemia Hyperglycemia In The Pregnant Patient
Hypoglycemia Hyperglycemia In The Pregnant PatientHypoglycemia Hyperglycemia In The Pregnant Patient
Hypoglycemia Hyperglycemia In The Pregnant Patient
 

Viewers also liked

Kenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherie
Kenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherieKenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherie
Kenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherie
Institut de l'Elevage - Idele
 
Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN
taherzy1406
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
Suhashis Mukherjee
 
Congenital abomalities
Congenital abomalitiesCongenital abomalities
Congenital abomalities
Tana Kiak
 
Miscarriage & stillbirth
Miscarriage & stillbirthMiscarriage & stillbirth
Miscarriage & stillbirthNorthside ISD
 
Pregnancy Complications - Whitney Lewis
Pregnancy Complications - Whitney LewisPregnancy Complications - Whitney Lewis
Pregnancy Complications - Whitney Lewis
bcooper876
 
Assessment fetal growth
Assessment fetal growthAssessment fetal growth
Assessment fetal growth
joemax3
 
Bleeding in late pregnancy
Bleeding in late pregnancyBleeding in late pregnancy
Bleeding in late pregnancy
magdy abdel
 
Early Pregnancy Complication by UM
Early Pregnancy Complication by UMEarly Pregnancy Complication by UM
Early Pregnancy Complication by UMDr. Rubz
 
Management of the Infertile couple in a Primary Care Setting. Part 2
Management of the Infertile couple in a Primary Care Setting. Part 2Management of the Infertile couple in a Primary Care Setting. Part 2
Management of the Infertile couple in a Primary Care Setting. Part 2
Milie Nwoye
 
Normal and abnormal fetal growth
Normal and abnormal fetal growthNormal and abnormal fetal growth
Normal and abnormal fetal growth
Dr Max Mongelli
 
Abnormalities of early pregnancy
Abnormalities of early pregnancyAbnormalities of early pregnancy
Abnormalities of early pregnancy
Julia Rasch
 
Macrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduareMacrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduare
Faculty of Medicine,Zagazig University,EGYPT
 
Gestational diabetes case study 2nd one
Gestational diabetes case study 2nd oneGestational diabetes case study 2nd one
Gestational diabetes case study 2nd oneLisette Allender
 
2. mongolia(high risk maternity care overview)
2. mongolia(high risk maternity care overview)2. mongolia(high risk maternity care overview)
2. mongolia(high risk maternity care overview)Hishgeeubuns
 
Female infertility (2)
Female infertility (2)Female infertility (2)
Female infertility (2)
obgymgmcri
 
Third trimester Bleeding
Third trimester BleedingThird trimester Bleeding
Third trimester Bleeding
Tana Kiak
 

Viewers also liked (20)

Gestational Diabetes
Gestational DiabetesGestational Diabetes
Gestational Diabetes
 
Kenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherie
Kenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherieKenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherie
Kenaveau - Konsommation d'ENergie pour l'Alimentation du VEAU de boucherie
 
Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN
 
GDM
GDMGDM
GDM
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
Congenital abomalities
Congenital abomalitiesCongenital abomalities
Congenital abomalities
 
Miscarriage & stillbirth
Miscarriage & stillbirthMiscarriage & stillbirth
Miscarriage & stillbirth
 
Pregnancy Complications - Whitney Lewis
Pregnancy Complications - Whitney LewisPregnancy Complications - Whitney Lewis
Pregnancy Complications - Whitney Lewis
 
Assessment fetal growth
Assessment fetal growthAssessment fetal growth
Assessment fetal growth
 
Bleeding in late pregnancy
Bleeding in late pregnancyBleeding in late pregnancy
Bleeding in late pregnancy
 
Early Pregnancy Complication by UM
Early Pregnancy Complication by UMEarly Pregnancy Complication by UM
Early Pregnancy Complication by UM
 
Management of the Infertile couple in a Primary Care Setting. Part 2
Management of the Infertile couple in a Primary Care Setting. Part 2Management of the Infertile couple in a Primary Care Setting. Part 2
Management of the Infertile couple in a Primary Care Setting. Part 2
 
Normal and abnormal fetal growth
Normal and abnormal fetal growthNormal and abnormal fetal growth
Normal and abnormal fetal growth
 
Infections in pregnancy, foetus and neonates
Infections in pregnancy, foetus and neonatesInfections in pregnancy, foetus and neonates
Infections in pregnancy, foetus and neonates
 
Abnormalities of early pregnancy
Abnormalities of early pregnancyAbnormalities of early pregnancy
Abnormalities of early pregnancy
 
Macrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduareMacrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduare
 
Gestational diabetes case study 2nd one
Gestational diabetes case study 2nd oneGestational diabetes case study 2nd one
Gestational diabetes case study 2nd one
 
2. mongolia(high risk maternity care overview)
2. mongolia(high risk maternity care overview)2. mongolia(high risk maternity care overview)
2. mongolia(high risk maternity care overview)
 
Female infertility (2)
Female infertility (2)Female infertility (2)
Female infertility (2)
 
Third trimester Bleeding
Third trimester BleedingThird trimester Bleeding
Third trimester Bleeding
 

Similar to Gestational diabetes Q & A

Postpartum Gestational Diabetes: Opportunities for Screening for Type 2 Diabetes
Postpartum Gestational Diabetes: Opportunities for Screening for Type 2 DiabetesPostpartum Gestational Diabetes: Opportunities for Screening for Type 2 Diabetes
Postpartum Gestational Diabetes: Opportunities for Screening for Type 2 Diabetes
Iris Thiele Isip-Tan
 
Epidemiology of GDM in Zagazig
Epidemiology of GDM in Zagazig Epidemiology of GDM in Zagazig
Epidemiology of GDM in Zagazig
Mohammad Gamal
 
ueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobnaueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobna
ueda2015
 
HYPERGLYCEMIA IN PREGNANCY by Dr Selim
HYPERGLYCEMIA IN PREGNANCY by Dr SelimHYPERGLYCEMIA IN PREGNANCY by Dr Selim
HYPERGLYCEMIA IN PREGNANCY by Dr Selim
Bangabandhu Sheikh Mujib Medical University
 
Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...
Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...
Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...
Bushra Zahid Saeed
 
Diabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico MecacciDiabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico Mecacci
robertobottino1
 
Predizione e prevenzione della Preeclampsia - Adriana Valcamonico
Predizione e prevenzione della Preeclampsia - Adriana ValcamonicoPredizione e prevenzione della Preeclampsia - Adriana Valcamonico
Predizione e prevenzione della Preeclampsia - Adriana Valcamonico
robertobottino1
 
Diabetes and macrosomia
Diabetes and macrosomiaDiabetes and macrosomia
Diabetes and macrosomiahelix1661
 
Effects of maternal hyperglycemia on fetus and neonate
Effects of maternal hyperglycemia on fetus and neonateEffects of maternal hyperglycemia on fetus and neonate
Effects of maternal hyperglycemia on fetus and neonate
Dr. Saad Saleh Al Ani
 
Riegert Johnson Genetics Ver I.pptx
Riegert Johnson Genetics Ver I.pptxRiegert Johnson Genetics Ver I.pptx
Riegert Johnson Genetics Ver I.pptx
Douglas Riegert-Johnson
 
Diabetes in pregnancy Dr.Pasham Sharath Chandra
Diabetes in pregnancy Dr.Pasham Sharath ChandraDiabetes in pregnancy Dr.Pasham Sharath Chandra
Diabetes in pregnancy Dr.Pasham Sharath Chandra
Pasham sharath
 
Universal screening for gestational diabetes by DIPSI test by Dr.Preksha
Universal screening for gestational diabetes by DIPSI test by Dr.PrekshaUniversal screening for gestational diabetes by DIPSI test by Dr.Preksha
Universal screening for gestational diabetes by DIPSI test by Dr.Preksha
Dr. Preksha Jain
 
Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes MellitusDr. Rubz
 
Gestational Diabetes Mellitus - DevanRaj
Gestational Diabetes Mellitus - DevanRajGestational Diabetes Mellitus - DevanRaj
Gestational Diabetes Mellitus - DevanRaj
Mohd Hanafi
 
Diabetes gestacional
Diabetes gestacionalDiabetes gestacional
Cell-free DNA test oltre le comuni aneuploidie
Cell-free DNA test oltre le comuni aneuploidieCell-free DNA test oltre le comuni aneuploidie
Cell-free DNA test oltre le comuni aneuploidie
Roberto Scarafia
 
Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)
Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)
Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)
Endocrinology Department, BSMMU
 
GDM (gestational Diabetes melitus).pptx
GDM (gestational Diabetes melitus).pptxGDM (gestational Diabetes melitus).pptx
GDM (gestational Diabetes melitus).pptx
ControlDiabetes1
 

Similar to Gestational diabetes Q & A (20)

Postpartum Gestational Diabetes: Opportunities for Screening for Type 2 Diabetes
Postpartum Gestational Diabetes: Opportunities for Screening for Type 2 DiabetesPostpartum Gestational Diabetes: Opportunities for Screening for Type 2 Diabetes
Postpartum Gestational Diabetes: Opportunities for Screening for Type 2 Diabetes
 
Epidemiology of GDM in Zagazig
Epidemiology of GDM in Zagazig Epidemiology of GDM in Zagazig
Epidemiology of GDM in Zagazig
 
ueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobnaueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobna
 
HYPERGLYCEMIA IN PREGNANCY by Dr Selim
HYPERGLYCEMIA IN PREGNANCY by Dr SelimHYPERGLYCEMIA IN PREGNANCY by Dr Selim
HYPERGLYCEMIA IN PREGNANCY by Dr Selim
 
Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...
Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...
Gestational Diabetes Mellitus 2020, Authors; Miss Bushra Zahid Saeed MRCOG Mi...
 
Diabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico MecacciDiabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico Mecacci
 
Predizione e prevenzione della Preeclampsia - Adriana Valcamonico
Predizione e prevenzione della Preeclampsia - Adriana ValcamonicoPredizione e prevenzione della Preeclampsia - Adriana Valcamonico
Predizione e prevenzione della Preeclampsia - Adriana Valcamonico
 
Diabetes and macrosomia
Diabetes and macrosomiaDiabetes and macrosomia
Diabetes and macrosomia
 
Effects of maternal hyperglycemia on fetus and neonate
Effects of maternal hyperglycemia on fetus and neonateEffects of maternal hyperglycemia on fetus and neonate
Effects of maternal hyperglycemia on fetus and neonate
 
Riegert Johnson Genetics Ver I.pptx
Riegert Johnson Genetics Ver I.pptxRiegert Johnson Genetics Ver I.pptx
Riegert Johnson Genetics Ver I.pptx
 
Diabetes in pregnancy Dr.Pasham Sharath Chandra
Diabetes in pregnancy Dr.Pasham Sharath ChandraDiabetes in pregnancy Dr.Pasham Sharath Chandra
Diabetes in pregnancy Dr.Pasham Sharath Chandra
 
Universal screening for gestational diabetes by DIPSI test by Dr.Preksha
Universal screening for gestational diabetes by DIPSI test by Dr.PrekshaUniversal screening for gestational diabetes by DIPSI test by Dr.Preksha
Universal screening for gestational diabetes by DIPSI test by Dr.Preksha
 
Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
 
Gestational Diabetes Mellitus - DevanRaj
Gestational Diabetes Mellitus - DevanRajGestational Diabetes Mellitus - DevanRaj
Gestational Diabetes Mellitus - DevanRaj
 
Diabetes gestacional
Diabetes gestacionalDiabetes gestacional
Diabetes gestacional
 
Cell-free DNA test oltre le comuni aneuploidie
Cell-free DNA test oltre le comuni aneuploidieCell-free DNA test oltre le comuni aneuploidie
Cell-free DNA test oltre le comuni aneuploidie
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
 
Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)
Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)
Adverse pregnancy outcome in Gestational Diabetes Mellitus (GDM)
 
Polycystic ovary syndrome
Polycystic ovary syndromePolycystic ovary syndrome
Polycystic ovary syndrome
 
GDM (gestational Diabetes melitus).pptx
GDM (gestational Diabetes melitus).pptxGDM (gestational Diabetes melitus).pptx
GDM (gestational Diabetes melitus).pptx
 

More from Iris Thiele Isip-Tan

Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
Artificial Intelligence and Health Research
Artificial Intelligence and Health ResearchArtificial Intelligence and Health Research
Artificial Intelligence and Health Research
Iris Thiele Isip-Tan
 
AI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataAI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of Data
Iris Thiele Isip-Tan
 
Artificial Intelligence in Health Professions Education
Artificial Intelligence in Health Professions EducationArtificial Intelligence in Health Professions Education
Artificial Intelligence in Health Professions Education
Iris Thiele Isip-Tan
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
Iris Thiele Isip-Tan
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Iris Thiele Isip-Tan
 
Artificial Intelligence in Biology Research and Instruction
Artificial Intelligence in Biology Research and InstructionArtificial Intelligence in Biology Research and Instruction
Artificial Intelligence in Biology Research and Instruction
Iris Thiele Isip-Tan
 
Artificial Intelligence in Health and Research
Artificial Intelligence in Health and ResearchArtificial Intelligence in Health and Research
Artificial Intelligence in Health and Research
Iris Thiele Isip-Tan
 
Artificial Intelligence: Ethical Issues in Residency Training
Artificial Intelligence: Ethical Issues in Residency TrainingArtificial Intelligence: Ethical Issues in Residency Training
Artificial Intelligence: Ethical Issues in Residency Training
Iris Thiele Isip-Tan
 
Use of AI: Misinformation on Social Media
Use of AI: Misinformation on Social MediaUse of AI: Misinformation on Social Media
Use of AI: Misinformation on Social Media
Iris Thiele Isip-Tan
 
Blended Learning: Strategies for Student Engagement
Blended Learning: Strategies for Student EngagementBlended Learning: Strategies for Student Engagement
Blended Learning: Strategies for Student Engagement
Iris Thiele Isip-Tan
 
EMR Documentation: Challenges and Opportunities
EMR Documentation: Challenges and Opportunities EMR Documentation: Challenges and Opportunities
EMR Documentation: Challenges and Opportunities
Iris Thiele Isip-Tan
 
How EMRs Improve Patient Management
How EMRs Improve Patient Management How EMRs Improve Patient Management
How EMRs Improve Patient Management
Iris Thiele Isip-Tan
 
AI in Healthcare: Risks, Challenges, Benefits
AI in Healthcare: Risks, Challenges, BenefitsAI in Healthcare: Risks, Challenges, Benefits
AI in Healthcare: Risks, Challenges, Benefits
Iris Thiele Isip-Tan
 
Social Media: Navigating the Ethics of Influence on Public Trust
Social Media: Navigating the Ethics of Influence on Public Trust Social Media: Navigating the Ethics of Influence on Public Trust
Social Media: Navigating the Ethics of Influence on Public Trust
Iris Thiele Isip-Tan
 
Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits
Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits
Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits
Iris Thiele Isip-Tan
 
Gamification: Gen Z Teaching & Learning
Gamification: Gen Z Teaching & LearningGamification: Gen Z Teaching & Learning
Gamification: Gen Z Teaching & Learning
Iris Thiele Isip-Tan
 
Telepediatrics: Moving Toward Usual Care
Telepediatrics: Moving Toward Usual Care Telepediatrics: Moving Toward Usual Care
Telepediatrics: Moving Toward Usual Care
Iris Thiele Isip-Tan
 
Role of Social Media in Healthcare: An Internist's Perspective
Role of Social Media in Healthcare: An Internist's PerspectiveRole of Social Media in Healthcare: An Internist's Perspective
Role of Social Media in Healthcare: An Internist's Perspective
Iris Thiele Isip-Tan
 

More from Iris Thiele Isip-Tan (20)

Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
Artificial Intelligence and Health Research
Artificial Intelligence and Health ResearchArtificial Intelligence and Health Research
Artificial Intelligence and Health Research
 
AI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataAI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of Data
 
Artificial Intelligence in Health Professions Education
Artificial Intelligence in Health Professions EducationArtificial Intelligence in Health Professions Education
Artificial Intelligence in Health Professions Education
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
Artificial Intelligence in Biology Research and Instruction
Artificial Intelligence in Biology Research and InstructionArtificial Intelligence in Biology Research and Instruction
Artificial Intelligence in Biology Research and Instruction
 
Artificial Intelligence in Health and Research
Artificial Intelligence in Health and ResearchArtificial Intelligence in Health and Research
Artificial Intelligence in Health and Research
 
Artificial Intelligence: Ethical Issues in Residency Training
Artificial Intelligence: Ethical Issues in Residency TrainingArtificial Intelligence: Ethical Issues in Residency Training
Artificial Intelligence: Ethical Issues in Residency Training
 
Use of AI: Misinformation on Social Media
Use of AI: Misinformation on Social MediaUse of AI: Misinformation on Social Media
Use of AI: Misinformation on Social Media
 
Blended Learning: Strategies for Student Engagement
Blended Learning: Strategies for Student EngagementBlended Learning: Strategies for Student Engagement
Blended Learning: Strategies for Student Engagement
 
EMR Documentation: Challenges and Opportunities
EMR Documentation: Challenges and Opportunities EMR Documentation: Challenges and Opportunities
EMR Documentation: Challenges and Opportunities
 
How EMRs Improve Patient Management
How EMRs Improve Patient Management How EMRs Improve Patient Management
How EMRs Improve Patient Management
 
AI in Healthcare: Risks, Challenges, Benefits
AI in Healthcare: Risks, Challenges, BenefitsAI in Healthcare: Risks, Challenges, Benefits
AI in Healthcare: Risks, Challenges, Benefits
 
Social Media: Navigating the Ethics of Influence on Public Trust
Social Media: Navigating the Ethics of Influence on Public Trust Social Media: Navigating the Ethics of Influence on Public Trust
Social Media: Navigating the Ethics of Influence on Public Trust
 
Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits
Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits
Artificial Intelligence in Healthcare: Risks, Challenges, and Benefits
 
Gamification: Gen Z Teaching & Learning
Gamification: Gen Z Teaching & LearningGamification: Gen Z Teaching & Learning
Gamification: Gen Z Teaching & Learning
 
Telepediatrics: Moving Toward Usual Care
Telepediatrics: Moving Toward Usual Care Telepediatrics: Moving Toward Usual Care
Telepediatrics: Moving Toward Usual Care
 
Role of Social Media in Healthcare: An Internist's Perspective
Role of Social Media in Healthcare: An Internist's PerspectiveRole of Social Media in Healthcare: An Internist's Perspective
Role of Social Media in Healthcare: An Internist's Perspective
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

Gestational diabetes Q & A

  • 1. 2 Mar 2012 GESTATIONAL DIABETES MANAGEMENT Iris Thiele Isip Tan MD, MSc, FPCP, FPSEM Clinical Associate Professor, UP College of Medicine Wednesday, November 21, 12
  • 2. Q1 Which of the following women will you screen for gestational diabetes? a) 25 y.o. G1P0 whose mother has diabetes b) 38 y.o. G3P0 with recurrent first- trimester abortions c) 27 y.o. G2P1 d) All of the above Wednesday, November 21, 12
  • 3. Unite for Diabetes CPG 2010 All pregnant women should be screened for GDM. Wednesday, November 21, 12
  • 4. Risky Filipino women are at increased risk for diabetes in pregnancy. ASGODIP Data n/N Low risk 35/853 High risk 136/350 171/1203 Overall 14.2% Litonjua AD et al. AFES Study Group on Diabetes in Pregnancy: Preliminary Data on Prevalence. PJIM 1996:34:67-68. Wednesday, November 21, 12
  • 5. Risky Macrosomia Shoulder Dystocia Increased risk of perinatal morbidity Birth injuries Hypoglycemia http://www.flickr.com/photos/mikewade/3267336862/ http://www.flickr.com/photos/jessicafm/280232106/ http://www.flickr.com/photos/clairity/1385780317/ http://www.flickr.com/photos/tessawatson/379265818/ Wednesday, November 21, 12
  • 6. Risky Cesearean Section Preeclampsia Increased risk of maternal morbidity Pregnancy-induced hypertension Type 2 diabetes mellitus http://www.flickr.com/photos/ulybug/512369383/ http://www.flickr.com/photos/j2dread/4501366303/ http://www.flickr.com/photos/78428166@N00/4921825364/ Wednesday, November 21, 12
  • 7. International Diabetes Federation (2009) Global Guideline on Pregnancy and Diabetes “... women with GDM without risk factors appear to be no different from women with GDM and risk factors.” Wednesday, November 21, 12
  • 8. Q1 Which of the following women will you screen for gestational diabetes? a) 25 y.o. G1P0 whose mother has diabetes b) 38 y.o. G3P0 with recurrent first- trimester abortions c) 27 y.o. G2P1 d) All of the above Wednesday, November 21, 12
  • 9. Q2 Which of the following factors best predict risk of GDM? a) prior history of GDM b) glucosuria c) family history of diabetes d) prior macrosomic baby Wednesday, November 21, 12
  • 10. Prior history of GDM (OR 23.6 [95%CI 11.6, 48.0])3 Glucosuria (OR 9.04 [95%CI 2.6, 63.7]2; PPV 50% 4) Family history of diabetes (OR 7.1 [95%CI 5.6, 8.9]1; OR 2.74 [95%CI 1.47, 5.11]3) Prior macrosomic baby (OR 5.59 [95%CI 2.68, 11.7])3 Age >25 years old (OR 1.9 [95%CI 1.3, 2.7]1; OR 3.37 [95%CI 1.45, 7.85]3) Risk Factors for GDM UNITE CPG Wednesday, November 21, 12
  • 11. Diagnosis of polycystic ovary syndrome (OR 2.89 [95%CI 1.68, 4.98])5 Overweight or obese before pregnancy (BMI >27 kg/m2 OR 2.3 [95%CI 1.6, 3.3]1; BMI>30 kg/ m2 OR 2.65 [95%CI 1.36, 5.14]3 Macrosomia in current pregnancy (PPV 40% 4) Polyhydramnios in current pregancy (PPV 40% 4) Intake of drugs affecting carbohydrate metabolism Risk Factors for GDM UNITE CPG Wednesday, November 21, 12
  • 12. Q2 Which of the following factors best predict risk of GDM? a) prior history of GDM b) glucosuria c) family history of diabetes d) prior macrosomic baby Wednesday, November 21, 12
  • 13. Q3 For pregnant women, when should testing be done? a) Test high-risk women at the soonest possible time b) Women without risk factors should be tested between 24-28 wks AOG c) Testing for gestational diabetes should still be carried out in women at risk even beyond 24-28 wks AOG d) All of the above Wednesday, November 21, 12
  • 14. ASGODIP (Veterans Memorial Medical Center) AOG tested % 21-30 31-40 <20 weeks weeks weeks n=19 n = 74 n = 60 Negative 95 92 85 for GDM Positive 5 8 15 for GDM Bihasa MTG et al. Screening for gestational diabetes: Report from ASGODIP participating hospital: Veterans Memorial Medical Center. PJIM 1996:34:57-61. Testing Wednesday, November 21, 12
  • 15. Q3 For pregnant women, when should testing be done? a) Test high-risk women at the soonest possible time b) Women without risk factors should be tested between 24-28 wks AOG c) Testing for gestational diabetes should still be carried out in women at risk even beyond 24-28 wks AOG d) All of the above Wednesday, November 21, 12
  • 16. Q4 Which test should be used to screen for GDM? a) 75-g OGTT b) 100-g OGTT c) 50-g GCT d) FBS Wednesday, November 21, 12
  • 17. Capillary blood glucose ★ RBS ★ Fructosamine ★ FBS ★ Hba1c ★ Urine glucose NOT to be used for diagnosis of GDM Use OGTT Wednesday, November 21, 12
  • 18. One- step 50-g glucose Oral glucose challenge tolerance test (OGTT) test (GCT) 75-g or 100 g “A one-stage definitive procedure is preferred.” International Diabetes Federation (2009) Global Guideline on Pregnancy & Diabetes Wednesday, November 21, 12
  • 19. OGTT 100-g OGTT high glucose load often unpalatable 100-g OGTT duration 75-g OGTT 100-g more 3 hours international cumbersome; standard in 4 blood non-pregnant samples Wednesday, November 21, 12
  • 20. CPG Philippine Diabetes CPG has endorsed the use of the 75-g OGTT. Wednesday, November 21, 12
  • 21. Q4 Which test should be used to screen for GDM? a) 75-g OGTT b) 100-g OGTT c) 50-g GCT d) FBS Wednesday, November 21, 12
  • 22. Q5 Which of the following is true of the OGTT procedure? a) Low CHO intake for past 3 days b) Fast for 10 to 16 h c) Slow walking is not permitted d) Supine position during test Wednesday, November 21, 12
  • 23. CHO intake of at least 150 g/day 3 days prior Fast for 10 to 16 hours 75 grams of anhydrous dextrose powder as chilled 25% solution (400 cc) flavored with calamansi Drink within 5 minutes (first swallow is time zero) Terminate test should nausea and vomiting occur Collect samples at 0, 1 and 2 hours OGTT Wednesday, November 21, 12
  • 24. Abstain from tobacco, coffee, tea, food and alcohol during test Sit upright and quietly during the test Slow walking is permitted but avoid vigorous exercise OGTT Wednesday, November 21, 12
  • 25. Q5 Which of the following is true of the OGTT procedure? a) Low CHO intake for past 3 days b) Fast for 10 to 16 h c) Slow walking is not permitted d) Supine position during test Wednesday, November 21, 12
  • 26. Q6 Which of the following results is/are consistent with GDM? a) 75-g OGTT: FBS 90 1h 190 2h 150 b) 75-g OGTT: FBS 98 1h 190 2h 150 c) 100-g OGTT: FBS 98 1h 190 2h 150 3h 140 d) All of the above Wednesday, November 21, 12
  • 27. CPG Thresholds ADA IADPSG for diagnosis 100-g 75-g 75-g* FBS 95 95 92 1h 180 180 180 2h 155 155 153 3h 140 - - * Requires only 1 threshold value exceeded Wednesday, November 21, 12
  • 28. Q6 Which of the following results is/are consistent with GDM? IADPSG a) 75-g OGTT: FBS 90 1h 190 2h 150 ADA b) 75-g OGTT: FBS 98 1h 190 2h 150 c) 100-g OGTT: FBS 98 1h 190 2h 150 3h 140 ADA d) All of the above Wednesday, November 21, 12
  • 29. CPG Thresholds ADA IADPSG for diagnosis 100-g 75-g 75-g* FBS 95 95 92 1h 180 180 180 2h 155 155 153 3h 140 - - * Requires only 1 threshold value exceeded Wednesday, November 21, 12
  • 30. OGTT ACOG recommends against IADPSG consensus Diagnosis of GDM based on the 1-step screening and diagnosis test outlined in the IADPSG guidelines is not recommended at this time because there is no evidence that diagnosis using these criteria leads to clinically significant improvement in maternal or newborn outcomes, and it would lead to a significant increase in healthcare costs. ACOG Committee on Obstetric Practice. Screening & Diagnosis of Gestational Diabetes Mellitus. Obstetrics & Gynecology 2011; 118(3):751-3 Wednesday, November 21, 12
  • 31. Q7 Which of the following is TRUE of dietary management for GDM? a) Do NOT prescribe less than 1500 cal/day for multiple pregnancy b) For overweight women, reduce energy intake by no more than 30% of habitual intake c) Monitor urine ketones at bedtime to detect starvation ketonuria d) Non-caloric sweeteners are NOT allowed. Wednesday, November 21, 12
  • 32. Diet Recommended Daily Caloric Intake Pregravid BMI Category kcal/kg/day Low (BMI <18.5 kg/m2) 36-40 Normal (BMI 18.5-24.9 kg/m2) 30 High (BMI 25-29.9 kg/m2) 24 Obese (BMI >29.9 kg/m2) 12 Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009) Wednesday, November 21, 12
  • 33. Diet For considerably overweight women with GDM, reduce energy intake by no more than 30% of habitual intake Total cal/day = 1,800-2,000 Not less than 2,000 cal/day if multiple pregnancy International Diabetes Federation (2009) Global Guideline on Pregnancy and Diabetes Wednesday, November 21, 12
  • 34. “Non-c aloric sweeteners may be used in moderation.” ADA GDM Position Statement 2004 Wednesday, November 21, 12
  • 35. Q7 Which of the following is TRUE of dietary management for GDM? a) Do NOT prescribe less than 1500 cal/day for multiple pregnancy b) For overweight women, reduce energy intake by no more than 30% of habitual intake c) Monitor urine ketones at bedtime to detect starvation ketonuria d) Non-caloric sweeteners are NOT allowed. Wednesday, November 21, 12
  • 36. Q8 For a woman with normal BMI, what is the allowed weight gain in pregnancy? a) <28-40 lbs b) 25-35 lbs c) 15-25 lbs d) 11-20 lbs Wednesday, November 21, 12
  • 37. Weight gain during pregnancy 12.5 kg British cohort of >3800 primigravidae eating without restriction Product of conception Fetus, placenta, amniotic fluid Maternal tissue expansion Uterus, breasts, blood volume Maternal fat reserve Text Wednesday, November 21, 12
  • 38. Rates of weight gain* Prepregnancy Total weight 2nd and 3rd BMI gain (lbs) trimester (lbs/week) Underweight 1 <28-40 BMI <18.5 (1-1.3) Normal weight 1 25-35 BMI 18.5-24.9 (0.8-1) Overweight 0.6 15-25 BMI 25.0-29.9 (0.5-0.7) Obese 0.5 11-20 BMI >30.0 (0.4-0.6) * Assume a 0.5-2.0 kg (1.1-4.4 lbs) weight gain in the first trimester IOM Wednesday, November 21, 12
  • 39. Q8 For a woman with normal BMI, what is the allowed weight gain in pregnancy? a) <28-40 lbs b) 25-35 lbs c) 15-25 lbs d) 11-20 lbs Wednesday, November 21, 12
  • 40. Q9 Which of the following is TRUE of self-monitoring of blood glucose? a) For women on dietary intervention alone, monitor BG 6x a day. b) For women treated with insulin, postprandial monitoring is superior to pre-prandial. c) If on insulin, test BG before breakfast to detect hypoglycemia. d) Daily SMBG does not appear to be superior to intermittent office monitoring. Wednesday, November 21, 12
  • 41. “For women treated with insulin, limited evidence indicates that postprandial monitoring is superior to preprandial monitoring.” ADA GDM Position Statement 2004 Wednesday, November 21, 12
  • 42. Diet only Monitor BG 4x a day (prebreakfast and 1 h after the first bite of food at each meal) AACE 2007 Wednesday, November 21, 12
  • 43. Q9 Which of the following is TRUE of self-monitoring of blood glucose? a) For women on dietary intervention alone, monitor BG 6x a day. 3x a day b) For women treated with insulin, postprandial monitoring is superior to pre-prandial. c) If on insulin, test BG before breakfast to detect hypoglycemia. Test at night d) Daily SMBG does not appear to be superior to intermittent office monitoring. Wednesday, November 21, 12
  • 44. Q10 What are the targets for SMBG? a) Between 60 to 90 mg/dL for fasting and less than 120 mg/dL 1 hour after the first bite of food at each meal (postprandial) b) Not more than 95 mg/dL for fasting and less than 120 mg/dL 2 hours postprandial c) 90 mg/dL for fasting and less than 140 mg/dL 2 hours postprandial d) None of the above Wednesday, November 21, 12
  • 45. Between 60 to 90 mg/dL (fasting) and less than 120 mg/dL (1 hour after the first bite of food at each meal) AACE 2007 Wednesday, November 21, 12
  • 46. Q10 What are the targets for SMBG? a) Between 60 to 90 mg/dL for fasting and less than 120 mg/dL 1 hour after the first bite of food at each meal (postprandial) b) Not more than 95 mg/dL for fasting and less than 120 mg/dL 2 hours postprandial c) 90 mg/dL for fasting and less than 140 mg/dL 2 hours postprandial d) None of the above Wednesday, November 21, 12
  • 47. Q11 Can we give Metformin for GDM? a) Yes b) No Wednesday, November 21, 12
  • 48. ★ Use of Metformin or glibenclamide during pregnancy NOT an approved indication ★ Discuss with patients ★ Obtain and document informed consent. Canadian Diabetes Association 2008 METFORMIN: Off-label use OHA Wednesday, November 21, 12
  • 49. Insulin remains the agent of choice “In poorly resourced areas of the world, the theoretical disadvantages of using oral glucose- lowering agents ... far less than the risks of non- treatment.” IDF 2009 Insulin Wednesday, November 21, 12
  • 50. Q11 Can we give Metformin for GDM? a) Yes b) No Wednesday, November 21, 12
  • 51. Q12 When and how should insulin be started in GDM? a) Consider insulin when diet and exercise fail to maintain glucose targets in 1-2 weeks b) Ultrasound shows incipient fetal macrosomia (AC >70th percentile) c) Start daily insulin at 0.1-0.3 u/kg BW d) All of the above Wednesday, November 21, 12
  • 52. Insulin Initiation ADA Protocol Fasting whole BG >95 mg/dL 1-h postprandial whole BG >140 mg/dL 2-h postprandial whole BG >120 mg/dL Dr. Jovanovic Fasting plasma glucose >90 mg/dL (5 mmol/L) 1-h PP whole BG >120 mg/dL (6.7 mmol/L) Insulin Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009) Wednesday, November 21, 12
  • 53. Q12 When and how should insulin be started in GDM? a) Consider insulin when diet and exercise fail to maintain glucose targets in 1-2 weeks b) Ultrasound shows incipient fetal macrosomia (AC >70th percentile) c) Start daily insulin at 0.1-0.3 u/kg BW d) All of the above Wednesday, November 21, 12
  • 54. Q13 Which of the following is true of management during labor? a) Give dextrose-containing IV fluids b) Give short-acting insulin for CBG>140 mg/dL c) Check CBG q hourly. d) All of the above Wednesday, November 21, 12
  • 55. Protocol for Spontaneous Delivery Infusion of 500 ml 5% dextrose/saline x4h CBG q 4h Give short-acting insulin for CBG >140 mg/dL L - Do se equal to mmol of CBG i.e. 12 u for 12 mmol/ u for - Dose equal to 1/20th of mg/dL of CBG i.e. 12 240 mg/dL Omit insulin for CBG <140 mg/dL ASGODIP Wednesday, November 21, 12
  • 56. After delivery Resume diet GDMs with high insulin requirements during pregnancy should have glucose profiles Give insulin if BG persistently high (>200 mg/dL) ASGODIP Wednesday, November 21, 12
  • 57. Q13 Which of the following is true of management during labor? a) Give dextrose-containing IV fluids b) Give short-acting insulin for CBG>140 mg/dL c) Check CBG q hourly. d) All of the above Wednesday, November 21, 12
  • 58. Q14 Which of the following is true of postpartum follow-up? a) Schedule 75-g OGTT 6 weeks after follow-up b) Measure FBS every 3 years c) Advise patient not to get pregnant again d) Breastfeeding should be limited Wednesday, November 21, 12
  • 59. Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009) Annual follow-up Measure FBS Assess weight reduction Review pregnancy plans Wednesday, November 21, 12
  • 60. Ff-up All patients with prior GDM should be educated re: lifestyle modifications Maintain normal body weight: MNT and physical activity Women with IFG or IGT postpartum: intensive MNT and individualized exercise program ADA GDM Position Statement 2004 Wednesday, November 21, 12
  • 61. Ff-up Planning subsequent pregnancies Plan future pregnancies in consultation with health care provider Assess glucose tolerance prior to conception to assure normoglycemia at time of conception Canadian Diabetes Association 2008 Wednesday, November 21, 12
  • 62. Q14 Which of the following is true of postpartum follow-up? a) Schedule 75-g OGTT 6 weeks after follow-up b) Measure FBS every 3 years c) Advise patient not to get pregnant again d) Breastfeeding should be limited Wednesday, November 21, 12
  • 63. Thank You http://www.endocrine-witch.net @endocrine_witch Image from http://wthr.frumph.net/ Wednesday, November 21, 12